No Known Direct Interaction Between Vascepa and Vitamin D
Vascepa (icosapent ethyl), a purified EPA omega-3 fatty acid, lowers triglycerides and reduces cardiovascular risk in high-risk patients. Vitamin D supports bone health, immune function, and cardiovascular wellness via calcium regulation and anti-inflammatory effects. No clinical studies or drug interaction databases report direct pharmacokinetic or pharmacodynamic interactions between Vascepa and vitamin D that amplify or diminish health benefits.[1][2]
Vascepa is not absorbed with vitamin D-dependent mechanisms, and neither alters the other's metabolism via CYP enzymes or transporters. Concurrent use appears safe based on prescribing information and interaction checkers.[3]
Potential Indirect Cardiovascular Synergies
Both may independently support heart health, leading users to combine them:
- Vascepa reduces major adverse cardiovascular events by 25% in statin-treated patients with elevated triglycerides (REDUCE-IT trial).[4]
- Vitamin D deficiency links to higher cardiovascular risk; supplementation (e.g., 2,000 IU daily) modestly lowers inflammation markers like CRP in deficient individuals.[5]
No trials test Vascepa plus vitamin D specifically. Observational data hints omega-3s like EPA might enhance vitamin D's anti-inflammatory role in coronary disease, but evidence is preliminary and not causal.[6]
Statin Context and Common Co-Use
Patients on Vascepa often take statins, which pair with vitamin D for muscle pain prevention (statins can deplete vitamin D).[7] Vascepa adds CV protection without raising statin-related risks. Vitamin D dosing remains standard (600-4,000 IU daily) regardless.[8]
Risks or Concerns with Combining Them
No heightened side effects noted:
- Vascepa risks: bleeding (especially with anticoagulants), atrial fibrillation.[3]
- Vitamin D risks: hypercalcemia at doses >10,000 IU daily long-term.[8]
Monitor vitamin D levels if deficient (<20 ng/mL), as correction benefits CV health broadly, not uniquely with Vascepa.[5]
Who Might Consider This Combo and Alternatives
High-triglyceride patients with CV risk and low vitamin D could benefit indirectly—test levels first. Alternatives include:
- Lovaza (EPA/DHA mix) for triglycerides, similar non-interaction with vitamin D.
- Lifestyle: fish intake boosts EPA; sun exposure aids vitamin D.
Consult a doctor for personalized advice; no FDA endorsement for synergy.
Sources
[1] Drugs.com Interaction Checker
[2] Vascepa FDA Label
[3] Medscape Vascepa Profile
[4] REDUCE-IT Trial (NEJM)
[5] AHA Vitamin D and CV Review
[6] Omega-3/Vitamin D Inflammation Study (Nutrients)
[7] Mayo Clinic Statins/Vitamin D
[8] NIH Vitamin D Fact Sheet